Search

everythinglearnresearchcommunity

for

Search:↓

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Melatonin improved mental health and metabolism in women with PCOS.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Taking 1mg of finasteride daily can mildly improve metabolic health and glucose regulation in men with male pattern baldness.

High-intensity interval training improves certain hormone levels and lipid profiles in women with PCOS.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Early hair loss links to metabolic issues in young Indian men.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

A boy with Sjogren-Larsson syndrome has skin and muscle symptoms due to a specific enzyme deficiency.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Women with early onset androgenetic alopecia have worse lipid profiles.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Patients with mycosis fungoides have a higher risk of heart disease.